Edition: Australia  
One News Page
“Probably the fastest-access news portal in the world”
> >

AstraZeneca ticks another box as U.S. approves severe asthma drug

Reuters Wednesday, 15 November 2017 ()
LONDON (Reuters) - AstraZeneca has achieved another milestone in rebuilding its drug portfolio with U.S. approval of a drug for severe asthma as the company battles to put patent losses on older medicines behind it.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

You Might Like


Other recent news in Health

SOUTH KOREA confirms H5N6 bird flu at duck farm, raises bird flu alert levelWhite House: True cost of OPIOID EPIDEMIC tops $500 billion
To Save Their Water Supply, COLORADO Farmers Taxed Themselves'My son is not a statistic': Mothers send pictures of fentanyl victims to JUSTIN TRUDEAU

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+